Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial
- Resource Type
- Source
- SKIN The Journal of Cutaneous Medicine. 7:s140
- Subject
Dermatology - Language
- ISSN
- 2574-1624